5AM Opportunities I, L.P.'s Net Worth
$173 Million
Who is 5AM Opportunities I, L.P.?
5AM Opportunities I, L.P. has an estimated net worth of $173 Million. This is based on reported shares across multiple companies, which include Enliven Therapeutics, Inc., CinCor Pharma, Inc., Entrada Therapeutics, Inc., Vor Biopharma Inc., Pear Therapeutics, Inc., Rallybio Corp, scPharmaceuticals Inc., Akouos, Inc., IDEAYA Biosciences, Inc., IMPEL NEUROPHARMA INC, Cabaletta Bio, Inc., and Aprea Therapeutics, Inc..
SEC CIK
5AM Opportunities I, L.P.'s CIK is 0001753000
Past Insider Trading and Trends
2021 was 5AM Opportunities I, L.P.'s most active year for acquiring shares with 18 total transactions. 5AM Opportunities I, L.P.'s most active month to acquire stocks was the month of September. 2022 was 5AM Opportunities I, L.P.'s most active year for disposing of shares, totalling 56 transactions. 5AM Opportunities I, L.P.'s most active month to dispose stocks was the month of October. 2022 saw 5AM Opportunities I, L.P. paying a total of $25,520,000.00 for 4,937,646 shares, this is the most they've acquired in one year. In 2020 5AM Opportunities I, L.P. cashed out on 93,242,818 shares for a total of $48,880,661.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Enliven Therapeutics, Inc. (ELVN) Snapshot price: $15.73
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -17.70% | -825.00K |
$14.90 | -$12,292,500.00 | 3.84M |
Feb 14
| |||
Form 4
| -9.69% | -500.00K |
$15.00 | -$7,500,000.00 | 4.66M |
Jan 31
| |||
Form 4
| -3.69% | -197.50K |
$15.00 | -$2,962,500.00 | 5.16M |
Sep 26
| |||
Form 4
| -7.59% | -440.00K |
$16.00 | -$7,040,000.00 | 5.36M |
Aug 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -4.94M |
—
|
—
|
0
|
Feb 24
| |||
Form 4
| +15.62% | 600K |
$30.00 | $18,000,000.00 | 4.44M |
Aug 15
| |||
Form 4
|
∞
| 4.34M |
$16.00 |
—
| 4.34M |
Jan 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Entrada Therapeutics, Inc. (TRDA) Snapshot price: $14.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +104.09% | 4.08M |
$20.00 |
—
| 7.99M |
Nov 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vor Biopharma Inc. (VOR) Snapshot price: $2.28
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.94% | -330.71K |
$15.30 | -$5,059,801.80 | 6.36M |
Nov 16
| |||
Form 4
|
∞
| 6.69M |
$18.00 |
—
| 6.69M |
Feb 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Rallybio Corp (RLYB) Snapshot price: $1.67
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.87% | -150.00K |
$12.50 | -$1,875,000.00 | 3.73M |
Jun 3
| |||
Form 4
| -2.51% | -100.00K |
$13.00 | -$1,300,000.00 | 3.88M |
May 23
| |||
Form 4
| -5.01% | -210.00K |
$13.05 | -$2,740,500.00 | 3.98M |
Feb 8
| |||
Form 4
| +77.83% | 615.38K |
$13.00 | $7,999,992.00 | 1.41M |
Aug 2
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||